1.35
price down icon0.74%   -0.01
after-market アフターアワーズ: 1.41 0.06 +4.44%
loading
前日終値:
$1.36
開ける:
$1.36
24時間の取引高:
1.67M
Relative Volume:
1.14
時価総額:
$395.37M
収益:
$6.23M
当期純損益:
$-95.90M
株価収益率:
-3.4615
EPS:
-0.39
ネットキャッシュフロー:
$-68.47M
1週間 パフォーマンス:
-2.88%
1か月 パフォーマンス:
+20.54%
6か月 パフォーマンス:
-11.18%
1年 パフォーマンス:
-2.17%
1日の値動き範囲:
Value
$1.33
$1.42
1週間の範囲:
Value
$1.24
$1.43
52週間の値動き範囲:
Value
$0.6513
$1.93

Precigen Inc Stock (PGEN) Company Profile

Name
名前
Precigen Inc
Name
セクター
Healthcare (1173)
Name
電話
301-556-9900
Name
住所
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Name
職員
202
Name
Twitter
@precigen
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
PGEN's Discussions on Twitter

PGEN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PGEN
Precigen Inc
1.35 395.37M 6.23M -95.90M -68.47M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
461.68 118.90B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
672.98 73.95B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
655.13 39.81B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
271.31 34.99B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
123.77 29.67B 3.30B -501.07M 1.03B -2.1146

Precigen Inc Stock (PGEN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-03-22 ダウングレード JP Morgan Neutral → Underweight
2023-05-23 開始されました JP Morgan Neutral
2022-11-18 開始されました Cantor Fitzgerald Overweight
2021-02-25 開始されました Stifel Buy
2021-02-22 開始されました Wells Fargo Overweight
2021-02-18 開始されました B. Riley Securities Buy
2020-05-08 開始されました H.C. Wainwright Buy
すべてを表示

Precigen Inc (PGEN) 最新ニュース

pulisher
Jan 27, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Sold by JPMorgan Chase & Co. - MarketBeat

Jan 27, 2025
pulisher
Jan 27, 2025

JPMorgan Chase & Co. Decreases Stake in Precigen, Inc. (NASDAQ:PGEN) - Defense World

Jan 27, 2025
pulisher
Jan 27, 2025

FY2024 EPS Estimates for Precigen Lifted by HC Wainwright - Defense World

Jan 27, 2025
pulisher
Jan 26, 2025

HC Wainwright Has Weak Outlook for Precigen FY2026 Earnings - Defense World

Jan 26, 2025
pulisher
Jan 26, 2025

Precigen’s (PGEN) Buy Rating Reiterated at HC Wainwright - Defense World

Jan 26, 2025
pulisher
Jan 24, 2025

Investors Purchase High Volume of Call Options on Precigen (NASDAQ:PGEN) - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

LexAurum Advisors LLC Raises Stock Holdings in Precigen, Inc. (NASDAQ:PGEN) - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

FY2026 EPS Estimates for Precigen Decreased by HC Wainwright - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Precigen (NASDAQ:PGEN) Earns Buy Rating from HC Wainwright - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Precigen Sees Unusually Large Options Volume (NASDAQ:PGEN) - Defense World

Jan 24, 2025
pulisher
Jan 23, 2025

Precigen's SWOT analysis: biotech firm's stock poised for growth with PRGN-2012 - MSN

Jan 23, 2025
pulisher
Jan 23, 2025

Knight-Swift Transportation Posts Upbeat Earnings, Joins TAL Education, LSI Industries, GE Aerospace And Other Big Stocks Moving Higher On Thursday - Benzinga

Jan 23, 2025
pulisher
Jan 23, 2025

Precigen (NASDAQ:PGEN) Given Buy Rating at HC Wainwright - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Precigen, Inc. (NASDAQ:PGEN) Stock Position Increased by Barclays PLC - Defense World

Jan 23, 2025
pulisher
Jan 23, 2025

Analysts Set Precigen, Inc. (NASDAQ:PGEN) Price Target at $6.33 - Defense World

Jan 23, 2025
pulisher
Jan 20, 2025

Precigen, Inc. (NASDAQ:PGEN) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 20, 2025
pulisher
Jan 19, 2025

Precigen, Inc. Regains Compliance with Nasdaq Listing Rules - Defense World

Jan 19, 2025
pulisher
Jan 18, 2025

Precigen shares rebound above Nasdaq minimum bid price - MSN

Jan 18, 2025
pulisher
Jan 16, 2025

Precigen shares rebound above Nasdaq minimum bid price By Investing.com - Investing.com Australia

Jan 16, 2025
pulisher
Jan 16, 2025

Should You Invest in Precigen (PGEN)? - MSN

Jan 16, 2025
pulisher
Jan 16, 2025

Jane Street Group LLC Reduces Stake in Precigen, Inc. (NASDAQ:PGEN) - Defense World

Jan 16, 2025
pulisher
Jan 15, 2025

Precigen's SWOT analysis: gene therapy stock focuses on RRP treatment By Investing.com - Investing.com Australia

Jan 15, 2025
pulisher
Jan 14, 2025

Precigen's SWOT analysis: gene therapy stock focuses on RRP treatment - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Precigen's (PGEN) "Market Outperform" Rating Reaffirmed at JMP Securities - MarketBeat

Jan 14, 2025
pulisher
Jan 13, 2025

Precigen to Present Plans for Realizing Commercial Vision for PR - GuruFocus.com

Jan 13, 2025
pulisher
Jan 13, 2025

Precigen Files BLA for Breakthrough RRP Treatment PRGN-2012, Targets 27,000 US Patients - StockTitan

Jan 13, 2025
pulisher
Jan 10, 2025

Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference - StreetInsider.com

Jan 10, 2025
pulisher
Jan 09, 2025

Precigen CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 09, 2025
pulisher
Jan 08, 2025

Barclays PLC Acquires 124,141 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World

Jan 08, 2025
pulisher
Jan 07, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Bought by Geode Capital Management LLC - Defense World

Jan 07, 2025
pulisher
Jan 05, 2025

PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally? - MSN

Jan 05, 2025
pulisher
Jan 03, 2025

Investors Buy Large Volume of Precigen Call Options (NASDAQ:PGEN) - Defense World

Jan 03, 2025
pulisher
Jan 02, 2025

Traders Purchase High Volume of Precigen Call Options (NASDAQ:PGEN) - MarketBeat

Jan 02, 2025
pulisher
Jan 01, 2025

Exploring 3 Prominent High Growth Tech Stocks In The United States - Simply Wall St

Jan 01, 2025
pulisher
Jan 01, 2025

Precigen Completes Regulatory Filing For Approval Of Gene Therapy To Treat Respiratory Papillomatosis: Retail Sentiment Surges Amid Stock Rally - MSN

Jan 01, 2025
pulisher
Jan 01, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Acquired by State Street Corp - Defense World

Jan 01, 2025
pulisher
Dec 31, 2024

Precigen Completes Regulatory Filing For Approval Of Gene Therapy To Treat Respiratory Papillomatosis: Retail - Asianet Newsable

Dec 31, 2024
pulisher
Dec 31, 2024

Stifel Financial Corp Raises Stock Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World

Dec 31, 2024
pulisher
Dec 30, 2024

Precigen, Inc. announced that it has received $79 million in funding -December 29, 2024 - Marketscreener.com

Dec 30, 2024
pulisher
Dec 30, 2024

Precigen’s SWOT analysis: gene therapy firm’s stock faces pivotal year By Investing.com - Investing.com Nigeria

Dec 30, 2024
pulisher
Dec 30, 2024

Precigen's SWOT analysis: gene therapy firm's stock faces pivotal year By Investing.com - Investing.com South Africa

Dec 30, 2024
pulisher
Dec 30, 2024

Precigen's SWOT analysis: gene therapy firm's stock faces pivotal year - Investing.com

Dec 30, 2024

Precigen Inc (PGEN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
大文字化:     |  ボリューム (24 時間):